/NRXCF
NRXCF Stock - NeutriSci International Inc.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.00+0.00%
+$0.00 (+0.00%) • Aug 15
67
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for NRXCF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.83
52W High$0.00
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $457,750 | $80,894 | $74,572 | $96,538 | $82,663 |
| Gross Profit | $-43,408 | $-20,547 | $-5,866 | $2,936 | $3,913 |
| Gross Margin | -9.5% | -25.4% | -7.9% | 3.0% | 4.7% |
| Operating Income | $-690,313 | $-1,502,709 | $-1,944,273 | $-1,651,449 | $-2,259,830 |
| Net Income | $-770,694 | $-1,572,197 | $-1,952,547 | $-1,612,868 | $-2,382,899 |
| Net Margin | -168.4% | -1943.5% | -2618.3% | -1670.7% | -2882.7% |
| EPS | $-0.00 | $-0.01 | $-0.01 | $-0.01 | $-0.02 |
Company Overview
NeutriSci International Inc. develops, markets, and distributes nutraceutical products in Canada, the United States, Europe, Asia, and South America. It offers neuenergy, an energy tablet designed to deliver enhanced focus and mental clarity. The company sells its products through a distribution network of retail and online channels. NeutriSci International Inc. has partnership with LaSanta Botanicals, Nutritional High, and Naturally Splendid. NeutriSci International Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
NRXCFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q3 2023
EPS Surprise History
Q4 21
No data
Q1 22
No data
Q2 22
No data
Q3 22
No data
Q4 22
No data
Q1 23
No data
Q2 23
No data
Q3 23
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Aug 25, 2025 | — | — | — | — |
Q2 2024 | Jun 6, 2024 | — | — | — | — |
Q2 2024 | May 14, 2024 | — | — | — | — |
Q3 2023 | Sep 30, 2023 | — | $-0.00 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.00 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.00 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.00 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.00 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.00 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.00 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.00 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.00 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.00 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.00 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.00 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.00 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.00 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.00 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.00 | — | — |
Q3 2019 | Sep 30, 2019 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about NRXCF
What is NRXCF's current stock price?
NeutriSci International Inc. (NRXCF) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for NRXCF?
No analyst price targets are currently available for this stock.
What sector is NeutriSci International Inc. in?
NeutriSci International Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is NRXCF's market cap?
NeutriSci International Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does NRXCF pay dividends?
No, NeutriSci International Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorELLXF
Elixinol Wellness Limited
$0.01
Mkt Cap: $0.0B
IDCN
Indocan Resources Inc.
$0.00
Mkt Cap: $0.0B
MSMY
MC Endeavors, Inc.
$0.00
Mkt Cap: $0.0B
NPHC
Nutra Pharma Corp.
$0.00
Mkt Cap: $0.0B
PHCG
Pure Harvest Corporate Group, Inc.
$0.01
Mkt Cap: $0.0B
PRCNF
Pure Global Cannabis Inc.
$0.00
Mkt Cap: $0.0B
STEK
Stemtech Corporation
$0.00
Mkt Cap: $0.0B
STMH
Stem Holdings, Inc.
$0.00
Mkt Cap: $0.0B
TRLFF
Maven Brands Inc.
$0.00
Mkt Cap: $0.0B
VIBEF
Vibe Growth Corporation
$0.05
Mkt Cap: $0.0B
Explore stocks similar to NRXCF for comparison